ROHTESH S MEHTA to Complement Inactivating Agents
This is a "connection" page, showing publications ROHTESH S MEHTA has written about Complement Inactivating Agents.
Connection Strength
0.219
-
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement. Bone Marrow Transplant. 2023 09; 58(9):991-999.
Score: 0.219
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.